Nuvalent, Inc. Cash and Equivalents

Quick Answer

Nuvalent, Inc. reported Cash and Equivalents of $261.75 million for fiscal year 2025.

Nuvalent, Inc. Cash and Equivalents — Annual History

Fiscal Year Cash and Equivalents YoY Change
2025 $261.75M +79.7%
2024 $145.69M -56.6%
2023 $335.39M +38.7%
2022 $241.81M +252.9%
2021 $68.53M +563.2%
2020 $10.33M +242.6%
2019 $3.02M

Quarterly Cash and Equivalents

Quarter Ending Cash and Equivalents YoY QoQ
September 30, 2025 $115.75M -68.7% -9.2%
June 30, 2025 $127.47M +64.1% +5.5%
March 31, 2025 $120.83M +22.7% -17.1%
December 31, 2024 $145.69M -56.6% -60.5%
September 30, 2024 $369.24M +317.5% +375.2%
June 30, 2024 $77.70M +9.6% -21.1%
March 31, 2024 $98.52M +9.3% -70.6%
December 31, 2023 $335.39M +38.7% +279.3%
  • Nuvalent, Inc. showed an increase of +79.7% in Cash and Equivalents compared to the prior fiscal year.
  • Over the 2019–2025 period, Nuvalent, Inc.’s cash and equivalents has grown by 8578.5% (from $3.02 million to $261.75 million).
  • The most recent figure is from Nuvalent, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment